The government and Pathology Australia have struck a deal on collection centre rents and brokers look at the implications for pathology providers.
Aristocrat Leisure stunned brokers by delivering a resounding upgrade to the earnings outlook, as it grows outright sales, market share, margins and new segments.
CSR delivered a credible FY16 result, brokers contend. Yet, while building demand extends for another 12-18 months, several believe the going is as good as it gets for CSR.
FNArena provides a weekly update of Australian listed corporate bond issues, current pricing and yield data.
FNArena’s weekly update on short positions in the Australian share market.
QBE Insurance has fleshed out its plans to deliver profit growth of more than 10% by 2018. Brokers laud the detail on targets but are aware that a lot needs to go right.
Incitec Pivot’s first half results were ahead of most broker forecasts, albeit from low-quality items. Still, the explosives business surprised with its resilience.
Weekly Update on ASX-listed companies buying in their own stock.
Orica has moved away from earnings growth forecasts for FY16 and cut its dividend as it hunkers down for more price and volume pressures in the months ahead.
Vocus Communications is consolidating its merger with M2 Telecommunications, encouraging two further brokers to initiate coverage.